Objective: This study assessed the impact of different modalities of delivery of opioid use disorder (OUD)-related care on several patient outcomes.
Methods: This study was conducted among patients newly diagnosed with OUD and receiving OUD-related care between March 2020 and March 2022, using data from Epic Cosmos. We examined the association between the most common modality of OUD-related care delivery (audio-only vs. audiovisual vs. in-person) and the number of emergency department (ED) visits for any overdose and opioid-specific overdose and receipt of medication treatment for OUD (MOUD; primary). We also examined the association between the most common modality of OUD-related care delivery and all-cause ED visits, hospitalizations, and psychiatric-related hospitalizations (secondary outcomes). We estimated logistic regression for receipt of MOUD and negative binomial for all other outcomes.
Results: Most patients primarily received OUD-related care in person (87.6 %, n = 159,351), followed by audiovisual visits (11.3 %, n = 20,629) and audio-only visits (1.1 %, n = 1,869). The mean (SD) ages for these groups were 51.7 (15.9), 47.1 (15.0), and 51.1 (15.8) years, respectively. Compared to receiving OUD-related care primarily in-person, receiving care predominantly through audio-only or audiovisual visits was associated with a modest decrease in number of all-cause ED visits. Receiving OUD-related care primarily through audiovisual visits, compared to in-person care, was associated with a slight increase in the odds of receiving MOUD. No statistically significant differences were found between the care delivery modalities and the other outcomes we examined.
Conclusion: Telehealth, delivered via audio-only or audiovisual methods, appears to provide care of similar quality to in-person OUD care and may modestly reduce OUD-related ED visits while slightly increasing MOUD receipt. These findings support continued delivery of OUD-related care through telehealth and continuation of COVID-19-related policies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847226 | PMC |
| http://dx.doi.org/10.1016/j.abrep.2025.100588 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Spatial Epidemiologic Analysis of Opioid Use Disorder Treatment in New York State.
Med Care
March 2025
New York State Office of Addiction Services and Supports, New York, NY.
Background: Opioid agonist treatments (OAT; methadone and buprenorphine) for opioid use disorder (OUD) reduce overdose death by more than 50%. Low population-level rates of OAT are missed opportunities to reduce OUD-related mortality.
Objective: We examined county-level OAT utilization patterns to guide state-level and county-level initiatives to improve equitable access and utilization in New York State (NYS).
Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study.
Addict Behav Rep
June 2025
Institute for Digital Health & Innovation, University of Arkansas for Medical Sciences Little Rock AR USA.
Objective: This study assessed the impact of different modalities of delivery of opioid use disorder (OUD)-related care on several patient outcomes.
Methods: This study was conducted among patients newly diagnosed with OUD and receiving OUD-related care between March 2020 and March 2022, using data from Epic Cosmos. We examined the association between the most common modality of OUD-related care delivery (audio-only vs.
Associations Between Social Determinants of Health and Opioid-Use Disorder Among Chronic Pain Patients From a Multi-Institutional Dataset.
Anesth Analg
December 2024
Department of Anesthesiology, Division of Perioperative Informatics, University of California San Diego, La Jolla, California.
Background: This study examined the association between opioid-use disorder (OUD)-related diagnoses (eg, opioid dependence) and social determinants of health (SDoH) among patients with chronic pain.
Methods: A cross-sectional study was performed using the All of Us dataset (including >70,000 patients) to measure associations between SDoH and OUD using population- and individual-level surveys. Mixed-effects multivariable regression models (random effect being zip code) were conducted for each of the key SDoH domains.
Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists.
Addict Sci Clin Pract
December 2024
Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Background: Pharmacists play a key role in combating the opioid-related overdose epidemic in the United States (US), but little is known about their experience and willingness to deliver preventive services for opioid use disorder (OUD).
Aims: This study seeks to identify correlates of pharmacists' concerns about drug use problems (prescription drug misuse/use disorder and illicit drug use/use disorder) as well as their practice experience delivering preventive services for OUD (e.g.
Opioid Use Disorder Treatment in Sexually and Gender Diverse Patients: A Retrospective Cohort Study.
J Clin Psychiatry
October 2024
Massachusetts General Hospital, Boston, Massachusetts.
This study assesses differences in opioid use disorder (OUD) treatment among sexually and gender diverse (SGD) vs non-SGD people. Using electronic health record data from a federally qualified health center, this retrospective cohort study explores OUD treatment for adults with an OUD diagnosis, as well as any clinic visit from January 2013 until June 2021 (N = 1,133), through review of medication prescriptions for OUD and OUD-related visits. Patients identifying as lesbian/gay had the lowest prevalence of OUD, with 1% (n = 231) of lesbian/gay patients having an OUD diagnosis, as compared to 1.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!